CMV
CMV
CMV
CMV
CMV
CMV
Chorioretinitis represents a spectrum of posterior uveitis with diverse etiologies including congenital infections (rubella, CMV, toxoplasmosis), tuberculosis, and syphilis, each requiring different treatment regimens.
Toxoplasma chorioretinitis is treated with oral trimethoprim-sulfamethoxazole or pyrimethamine-sulfadiazine, while CMV retinitis requires systemic ganciclovir or valganciclovir, making accurate etiology crucial.
Macular involvement is associated with worse visual prognosis, necessitating careful assessment of lesion location on imaging to guide clinical counseling and treatment urgency.
MRI with gadolinium enhancement is the optimal cross-sectional imaging modality for evaluating posterior uveitis and chorioretinitis, offering superior soft tissue contrast for detecting uveal, retinal, and associated inflammatory changes.
DWI sequences can identify active inflammatory processes by detecting diffusion restriction within the uvea and subretinal effusions, aiding in assessment of disease activity.
Chronic chorioretinitis may progress to globe calcification, making CT imaging valuable for detecting late-stage sequelae and assessing for phthisical changes.
Cross-sectional radiology (CT/MRI) is rarely employed for chorioretinitis, which is fundamentally a clinical and ophthalmic-imaging diagnosis — no displayable CT or MRI figures for chorioretinitis were retrieved in the literature, though the radiologic findings are well described.
[1] On the standard cross-sectional modalities, chorioretinitis/posterior uveitis manifests as:
MRI — increased gadolinium enhancement of the uveal tract (seen as the enhancing layer immediately deep to the low-signal sclera), with choroidal thickening and/or hyperenhancement from increased capillary permeability; abnormal vitreous signal on FLAIR from altered protein content; and, in cases with subretinal effusion, restricted diffusion on DWI within the uvea and effusions.
[1]
CT — uveoscleral thickening and enhancement, sometimes with posterior calcification in chronic disease; in parasitic (Toxocara) chorioretinitis, a noncalcified focal intraocular mass with irregular thickening of the uveoscleral coat and a normal-size globe (calcification favors retinoblastoma instead
When reporting chorioretinitis on MRI, clearly describe the uveal tract enhancement pattern (enhancing layer deep to the sclera), quantify retinal thickening in millimeters, note the presence of subretinal effusions on DWI, specify macular involvement status, and comment on any perineural or perimuscular inflammation to guide clinical prognosis and treatment decisions.